Patient-specific dose finding in seamless phase I/II clinical trials (Q5043686)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Patient-specific dose finding in seamless phase I/II clinical trials |
scientific article; zbMATH DE number 7596762
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Patient-specific dose finding in seamless phase I/II clinical trials |
scientific article; zbMATH DE number 7596762 |
Statements
Patient-specific dose finding in seamless phase I/II clinical trials (English)
0 references
6 October 2022
0 references
dose-finding study
0 references
dose-response model
0 references
optimum dose
0 references
patients' heterogeneity
0 references
seamless phase I/II trial
0 references
